Assets of Ascendis Pharma A/S from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
ifrs-full: EUR
Summary
Ascendis Pharma A/S quarterly Assets in EUR history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • Ascendis Pharma A/S Assets for the quarter ending 31 Dec 2024 was €1,179,495,000, a 43% increase year-over-year.
Source SEC data
View on sec.gov
Assets, Quarterly (EUR)
Assets, YoY Quarterly Change (%)

Ascendis Pharma A/S Quarterly Assets (EUR)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 €1,179,495,000 +€353,908,000 +43% 31 Dec 2024 20-F 12 Feb 2025 2024 FY
Q3 2024 €1,093,783,000 +€220,570,000 +25% 30 Sep 2024 6-K 14 Nov 2024 2024 Q3
Q1 2024 €802,504,000 -€163,770,000 -17% 31 Mar 2024 6-K 02 May 2024 2024 Q1
Q4 2023 €825,587,000 -€264,151,000 -24% 31 Dec 2023 20-F 12 Feb 2025 2024 FY
Q3 2023 €873,213,000 -€400,207,000 -31% 30 Sep 2023 6-K 07 Nov 2023 2023 Q3
Q2 2023 €823,823,000 -€503,008,000 -38% 30 Jun 2023 6-K 05 Sep 2023 2023 Q2
Q1 2023 €966,274,000 -€410,976,000 -30% 31 Mar 2023 6-K 27 Apr 2023 2023 Q1
Q4 2022 €1,089,738,000 +€4,817,000 +0.44% 31 Dec 2022 20-F 07 Feb 2024 2023 FY
Q3 2022 €1,273,420,000 +€68,187,000 +5.7% 30 Sep 2022 6-K 02 Nov 2022 2022 Q3
Q2 2022 €1,326,831,000 +€474,983,000 +56% 30 Jun 2022 6-K 10 Aug 2022 2022 Q2
Q1 2022 €1,377,250,000 +€411,937,000 +43% 31 Mar 2022 6-K 11 May 2022 2022 Q1
Q4 2021 €1,084,921,000 +€105,128,000 +11% 31 Dec 2021 20-F 16 Feb 2023 2022 FY
Q3 2021 €1,205,233,000 +€159,109,000 +15% 30 Sep 2021 6-K 10 Nov 2021 2021 Q3
Q2 2021 €851,848,000 +€291,241,000 +52% 30 Jun 2021 6-K 27 Aug 2021 2021 Q2
Q1 2021 €965,313,000 +€343,906,000 +55% 31 Mar 2021 6-K 27 May 2021 2021 Q1
Q4 2020 €979,793,000 +€303,061,000 +45% 31 Dec 2020 20-F 02 Mar 2022 2021 FY
Q3 2020 €1,046,124,000 +€311,165,000 +42% 30 Sep 2020 6-K 12 Nov 2020 0
Q2 2020 €560,607,000 -€206,550,000 -27% 30 Jun 2020 6-K 27 Aug 2020 2020 Q2
Q1 2020 €621,407,000 -€140,532,000 -18% 31 Mar 2020 6-K 19 May 2020 2020 Q1
Q4 2019 €676,732,000 +€357,764,000 +112% 31 Dec 2019 20-F 10 Mar 2021 2020 FY
Q3 2019 €734,959,000 +€399,725,000 +119% 30 Sep 2019 6-K 18 Nov 2019 2019 Q3
Q2 2019 €767,157,000 +€398,293,000 +108% 30 Jun 2019 6-K 28 Aug 2019 2019 Q2
Q1 2019 €761,939,000 +€397,113,000 +109% 31 Mar 2019 6-K 30 May 2019 2019 Q1
Q4 2018 €318,968,000 +€107,989,000 +51% 31 Dec 2018 20-F 03 Apr 2020 2019 FY
Q3 2018 €335,234,000 30 Sep 2018 6-K 28 Nov 2018 2018 Q3
Q2 2018 €368,864,000 30 Jun 2018 6-K 29 Aug 2018 2018 Q2
Q1 2018 €364,826,000 31 Mar 2018 6-K 30 May 2018 2018 Q1
Q4 2017 €210,979,000 +€20,908,000 +11% 31 Dec 2017 20-F 03 Apr 2019 2018 FY
Q4 2016 €190,071,000 31 Dec 2016 20-F 28 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.